Hospital Vall d'Hebron-ko ikertzaileekin lankidetzan egindako argitalpenak (33)

2019

  1. Anti-IL6-Receptor Tocilizumab in Refractory and Noninfectious Uveitic Cystoid Macular Edema: Multicenter Study of 25 Patients

    American Journal of Ophthalmology, Vol. 200, pp. 85-94

  2. Biallelic loss-of-function LACC1/FAMIN Mutations Presenting as Rheumatoid Factor-Negative Polyarticular Juvenile Idiopathic Arthritis

    Scientific Reports, Vol. 9, Núm. 1

  3. Clinical characteristics and genetic analyses of 187 patients with undefined autoinflammatory diseases

    Annals of the Rheumatic Diseases, Vol. 78, Núm. 10, pp. 1405-1411

  4. Unexpected relevant role of gene mosaicism in patients with primary immunodeficiency diseases

    Journal of Allergy and Clinical Immunology, Vol. 143, Núm. 1, pp. 359-368

2018

  1. Blau Syndrome–Associated Uveitis: Preliminary Results From an International Prospective Interventional Case Series

    American Journal of Ophthalmology, Vol. 187, pp. 158-166

  2. S100A12 and S100A8/9 proteins are biomarkers of articular disease activity in Blau syndrome

    Rheumatology (United Kingdom), Vol. 57, Núm. 7, pp. 1299-1304

2017

  1. Anti–Interleukin-6 Receptor Tocilizumab for Severe Juvenile Idiopathic Arthritis–Associated Uveitis Refractory to Anti–Tumor Necrosis Factor Therapy: A Multicenter Study of Twenty-Five Patients

    Arthritis and Rheumatology, Vol. 69, Núm. 3, pp. 668-675

  2. Novel evidences of atypical manifestations in cryopyrin-associated periodic syndromes

    Clinical and Experimental Rheumatology, Vol. 35, pp. S27-S31

  3. Preliminary Definitions for the Sonographic Features of Synovitis in Children

    Arthritis Care and Research, Vol. 69, Núm. 8, pp. 1217-1223

  4. Subcutaneous tocilizumab may be less effective than intravenous tocilizumab in the treatment of juvenile idiopathic arthritis-Associated uveitis

    Journal of Rheumatology

2016

  1. Efficacy of the Janus kinase 1/2 inhibitor ruxolitinib in the treatment of vasculopathy associated with TMEM173-activating mutations in 3 children

    Journal of Allergy and Clinical Immunology, Vol. 138, Núm. 6, pp. 1752-1755

  2. The Phenotype and Genotype of Mevalonate Kinase Deficiency: A Series of 114 Cases From the Eurofever Registry

    Arthritis and Rheumatology, Vol. 68, Núm. 11, pp. 2795-2805

2015

  1. Clinical and genetic features of Spanish patients with Mevalonate kinase deficiency

    Pediatric Rheumatology, Vol. 13, Núm. 1

  2. Phenotypic and genotypic characteristics of cryopyrin-associated periodic syndrome: A series of 136 patients from the Eurofever Registry

    Annals of the Rheumatic Diseases, Vol. 74, Núm. 11, pp. 2043-2049

2014

  1. Detection of synovitis by ultrasonography in clinically inactive juvenile idiopathic arthritis on and off medication

    Clinical and Experimental Rheumatology, Vol. 32, Núm. 4, pp. 597-603

  2. Health related quality of life measure in systemic pediatric rheumatic diseases and its translation to different languages: An international collaboration

    Pediatric Rheumatology, Vol. 12, Núm. 1

  3. Results from a multicentre international registry of Familial Mediterranean fever: Impact of environment on the expression of a monogenic disease in children

    Annals of the Rheumatic Diseases, Vol. 73, Núm. 4, pp. 662-667

  4. The phenotype of TNF receptor-associated autoinflammatory syndrome (TRAPS) at presentation: A series of 158 cases from the Eurofever/EUROTRAPS international registry

    Annals of the Rheumatic Diseases, Vol. 73, Núm. 12, pp. 2160-2167

  5. Tocilizumab for retinal vasoproliferative tumor secondary to juvenile idiopathic arthritis-associated uveitis: A case report

    Graefe's Archive for Clinical and Experimental Ophthalmology

2013

  1. Treatment of autoinflammatory diseases: Results from the Eurofever Registry and a literature review

    Annals of the Rheumatic Diseases, Vol. 72, Núm. 5, pp. 678-685